Artera vs Proscia Concentriq

Proscia's Concentriq is the platform a pathology department runs on its scanned slides: image management, case review and AI apps. AP-Dx is cleared for primary diagnosis of FFPE surgical pathology slides, first as K230839 in February 2024 and then as K261380 in August 2026, which the vendor's release says adds the Leica Aperio GT 450 DX, cloud deployment and a change control plan. The vendor reports 4,000+ hospitals and clinics and a Best in KLAS 2026 ranking.

Artera sells to a different person. A urologist or breast oncologist sends one patient's specimen and gets a prognostic report back, built from the existing H&E slides with no extra staining, and the vendor says results arrive within 1 to 2 days of receipt. Proscia's pages name clinical labs and biopharma as its customers. The pathology department buys Concentriq, and the treating clinician with a prostate or breast cancer diagnosis uses Artera.